FOLH1 and glycogen storage disease VI: Subsequent studies have affirmed PSMA PET-CT as the gold standard for detecting both low-volume and high-volume disease due to its exceptional ability to identify micrometastatic disease that may be missed by conventional imaging [27,28,29].